2022
DOI: 10.1681/asn.2021081073
|View full text |Cite
|
Sign up to set email alerts
|

Regrow or Repair: An Update on Potential Regenerative Therapies for the Kidney

Abstract: Fifteen years ago, this journal published a review outlining future options for regenerating the kidney. At that time, stem cell populations were being identified in multiple tissues, the concept of stem cell recruitment to a site of injury was of great interest, and the possibility of postnatal renal stem cells was growing in momentum. Since that time, we have seen the advent of human induced pluripotent stem cells, substantial advances in our capacity to both sequence and edit the genome, global and spatial … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
32
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 28 publications
(32 citation statements)
references
References 194 publications
0
32
0
Order By: Relevance
“…However, it is still difficult to fully reproduce the organ architecture and differentiation in vitro. With the discovery of iPS cells as a cell source for organ regeneration, advances in analytical technologies such as omics, and improvements in genome editing technology, technology has made great strides over the last 15 years [ 38 ]. Given the progress in the field of kidney regeneration, which requires regeneration of complex organ regeneration including urological tissues in vivo, I expect that hybrid organ regeneration technology based on chimera technology that borrows the developmental environment and structures of different animal species will facilitate the realization of 3D organ regeneration.…”
Section: Discussionmentioning
confidence: 99%
“…However, it is still difficult to fully reproduce the organ architecture and differentiation in vitro. With the discovery of iPS cells as a cell source for organ regeneration, advances in analytical technologies such as omics, and improvements in genome editing technology, technology has made great strides over the last 15 years [ 38 ]. Given the progress in the field of kidney regeneration, which requires regeneration of complex organ regeneration including urological tissues in vivo, I expect that hybrid organ regeneration technology based on chimera technology that borrows the developmental environment and structures of different animal species will facilitate the realization of 3D organ regeneration.…”
Section: Discussionmentioning
confidence: 99%
“…Further, joint profiling of chromatin accessibility and gene expression of healthy human kidneys (specimens acquired after mass nephrectomy) using singlenucleus RNA-seq and single-nucleus ATAC-seq (assay for transposase-accessible chromatin with high-throughput sequencing) captures open chromatin sites (Muto et al, 2021). This study reveals a small subset of proximal tubular cells, characterized by VCAM1 expression and NF-κB activity, without a preceding episode of AKI, are transcriptionally similar to "failed repair" cells (Muto et al, 2021;Little and Humphreys, 2022). This subset of cells may also contribute to renal fibrosis.…”
Section: A Distinct Subset Of Proximal Tubular Cells Acquires a New P...mentioning
confidence: 90%
“…Acute injury in proximal tubules (PTs) peaks 48 h after injury, followed by tubular proliferation (Chang-Panesso et al, 2019). Evidence strongly supports the conclusion that resident tubular epithelial cells serve as the primary cellular source that replenishes lost tubular cells (Humphreys et al, 2008;Schiessl, 2020); however, the identity of intratubular cells responsible for the repair is still controversial (Schiessl, 2020;Little and Humphreys, 2022).…”
Section: Tubular Epithelial Cells Proliferate Through Dedifferentiati...mentioning
confidence: 98%
See 1 more Smart Citation
“…Research on AKI and on the role of TEC must overcome three major challenges: a) finding a suitable way to study human disease pathomechanisms or effectively translate findings from mouse models to the human setting, b) provide clinicians with meaningful biomarkers to predict outcomes and c) understanding TEC repair to enable strategies to enhance regeneration and reduce scarring (7). It is reasonable to believe that answers to all three challenges may lie in the urine.…”
Section: Introductionmentioning
confidence: 99%